Interleukin-21 (IL-21) is a cytokine, a type of signaling molecule in the immune system, that plays a crucial role in regulating the immune response. It is produced by activated CD4+ T cells and natural killer T (NKT) cells. Recombinant human IL-21 is a laboratory-produced version of this cytokine, designed to mimic the natural protein’s effects in various research and therapeutic applications.
IL-21 is a member of the common gamma-chain family of cytokines, which also includes IL-2, IL-4, IL-7, IL-9, and IL-15. It is a four-α-helix bundle cytokine, structurally related to IL-2 and IL-15. The recombinant form of IL-21 is typically produced in Escherichia coli (E. coli) and purified using chromatographic techniques to ensure high purity and biological activity .
IL-21 has a wide range of biological functions, primarily related to the regulation of immune cells. It promotes the differentiation and proliferation of T cells, B cells, and natural killer (NK) cells. Specifically, IL-21 can:
These functions make IL-21 a key player in both innate and adaptive immunity, contributing to the body’s defense against infections and cancer.
Due to its potent immunomodulatory effects, recombinant IL-21 has been investigated for various therapeutic applications. It has shown promise in:
In research settings, recombinant IL-21 is used to study its effects on immune cells and to explore its potential therapeutic uses. It is commonly used in: